[Moderate hypofractionated adjuvant radiotherapy with simultaneous integrated boost for breast cancer].
作者信息
Krug David, Dunst Jürgen
机构信息
Klinik für Strahlentherapie/Radioonkologie, UKSH, Campus Kiel, Kiel, Deutschland.
出版信息
Strahlenther Onkol. 2023 Nov;199(11):1033-1035. doi: 10.1007/s00066-023-02144-z. Epub 2023 Sep 12.
Abstract
摘要
相似文献
1
[Moderate hypofractionated adjuvant radiotherapy with simultaneous integrated boost for breast cancer].[乳腺癌同步整合加量的中度低分割辅助放疗]
Strahlenther Onkol. 2023 Nov;199(11):1033-1035. doi: 10.1007/s00066-023-02144-z. Epub 2023 Sep 12.
2
Comment to "Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost".对“容积调强弧形放疗联合同步整合加量用于早期乳腺癌的大分割辅助放疗的II期试验的长期结果”的评论
Radiother Oncol. 2022 Jan;166:100. doi: 10.1016/j.radonc.2021.10.024. Epub 2021 Nov 29.
3
Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.保乳术后调强放疗同步推量与螺旋断层放疗 TomoEdge 标准推量应用的比较
Anticancer Res. 2021 Apr;41(4):1909-1920. doi: 10.21873/anticanres.14957.
4
Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.印度一家三级癌症护理中心开展的一项I/II期剂量学和临床可行性研究：采用容积调强弧形放疗对早期乳腺癌进行加速超分割辅助全乳放疗并同步整合加量。
J Egypt Natl Canc Inst. 2017 Mar;29(1):39-45. doi: 10.1016/j.jnci.2017.01.005.
5
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.保乳手术后辅助适形调强放疗：一项前瞻性试验结果。
Strahlenther Onkol. 2021 Jan;197(1):48-55. doi: 10.1007/s00066-020-01689-7. Epub 2020 Oct 1.
6
Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.容积旋转调强弧形放射治疗同步实施适形调强推量在早期乳腺癌辅助放疗中的 II 期临床试验的长期结果
Radiother Oncol. 2021 Nov;164:50-56. doi: 10.1016/j.radonc.2021.09.006. Epub 2021 Sep 17.
7
Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.保乳手术后的适形调强同步推量放疗：两项 II 期试验的长期结果。
Breast. 2022 Aug;64:136-142. doi: 10.1016/j.breast.2022.05.008. Epub 2022 Jun 2.
8
[Adjuvant radiation therapy for breast cancer].[乳腺癌辅助放疗]
Radiologie (Heidelb). 2023 Sep;63(9):693-702. doi: 10.1007/s00117-023-01198-5.
9
Dual partial arc volumetric-modulated arc therapy: The game changer for accelerated hypofractionated whole-breast radiotherapy with simultaneous integrated tumor cavity boost in early breast cancer - A comparative dosimetric study with single partial arc volumetric-modulated arc therapy.双部分弧容积调强弧形放疗：早期乳腺癌加速超分割全乳放疗同步瘤腔推量的变革者——与单部分弧容积调强弧形放疗的剂量学对比研究
J Cancer Res Ther. 2019 Jul-Sep;15(5):1005-1010. doi: 10.4103/jcrt.JCRT_922_17.
10
Long-term outcomes of patients with conserved breast cancer treated with adjuvant hypofractionated prone breast intensity-modulated radiation therapy.保乳术后接受辅助适形调强俯卧位放疗的乳腺癌患者的长期疗效。
J Med Imaging Radiat Oncol. 2020 Dec;64(6):845-851. doi: 10.1111/1754-9485.13072. Epub 2020 Jun 16.
本文引用的文献
1
Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward.中度分割仍然是乳腺癌全乳放射治疗的标准治疗方法：关于 FAST 和 FAST-Forward 的考虑。
Strahlenther Onkol. 2021 Apr;197(4):269-280. doi: 10.1007/s00066-020-01744-3. Epub 2021 Jan 28.
2
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial.指南变化对随机对照 HYPOSIB 试验中采用 Hypofractionation 和乳腺癌患者特征的影响。
Strahlenther Onkol. 2021 Sep;197(9):802-811. doi: 10.1007/s00066-020-01730-9. Epub 2020 Dec 15.
3
Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: A randomized clinical trial of KROG 15-03.早期乳腺癌术后调强放疗与三维适形放疗的随机临床试验：KROG 15-03 研究。
Radiother Oncol. 2021 Jan;154:179-186. doi: 10.1016/j.radonc.2020.09.043. Epub 2020 Sep 24.
4
Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.在一项随机 III 期试验中，比较早期乳腺癌或导管原位癌患者接受低分割与标准分割放疗的效果：DBCG HYPO 试验。
J Clin Oncol. 2020 Nov 1;38(31):3615-3625. doi: 10.1200/JCO.20.01363. Epub 2020 Sep 10.
5
Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.保乳治疗早期乳腺癌患者美容效果不佳的预测因素：Young boost 试验结果。
Radiother Oncol. 2018 Sep;128(3):434-441. doi: 10.1016/j.radonc.2018.06.020. Epub 2018 Jul 3.
6
Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.IMPORT HIGH试验（CRUK/06/003）对英国乳腺癌放疗实践的临床影响。
Br J Radiol. 2015;88(1056):20150453. doi: 10.1259/bjr.20150453. Epub 2015 Oct 22.
7
Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial.早期乳腺癌患者在显微镜下切缘未净的肿块切除术后，10 Gy与26 Gy的追加剂量放疗的疗效比较：欧洲癌症研究与治疗组织（EORTC）追加剂量放疗随机试验的10年结果
Radiother Oncol. 2009 Jan;90(1):80-5. doi: 10.1016/j.radonc.2008.07.011. Epub 2008 Aug 15.
Zotero 插件